In its advice published in December, PBAC noted there was a "significant risk" that people who did not meet the two criteria and particularly those who met one threshold but not the other would seek access to the subsidised drugs and therefore that a "risk sharing arrangement" with the company would be needed to manage the cost to the government
Any sudden or severe change in symptoms warrants medical attention, particularly if accompanied by intense abdominal pain or persistent vomiting
L-Carnitine: a valuable ally for muscle growth
Maryam Tabatabai Associate Vice President, Clinical Information Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Data Scientist Principal Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior Consultant panel Samantha Decker, PharmD Medical Pharmacy Clinical Pharmacist Natalee Felten, PharmD, BCPS Medical Pharmacy Clinical Pharmacist Andrea Henry, PharmD, MBA, BCPS Drug Information Pharmacist Principal Danny Melson Data Scientist Principal Katie Owen, PharmD, BCOP Clinical Program Pharmacist Principal All brand names are property of their respective owners